Kobayashi Pharmaceutical Co (FRA:KOY) Cyclically Adjusted Book per Share: €13.71 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KOY Kobayashi Pharmaceutical Co Ltd FRA:KOY
77 GF Score
Price €30.40
GF Value €26.16
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Kobayashi Pharmaceutical Co Cyclically Adjusted Book per Share?

Kobayashi Pharmaceutical Co FRA:KOY +0.66% 77 Cyclically Adjusted Book per Share is €13.71 as of Jun. 2026. GuruFocus rates FRA:KOY with a GF Score™ of 77/100 and a GF Value™ of €26.16 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kobayashi Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was €15.229. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €13.71 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Kobayashi Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Kobayashi Pharmaceutical Co was 8.90% per year. The lowest was 6.30% per year. And the median was 7.55% per year.

As of today (2026-09-05), Kobayashi Pharmaceutical Co's current stock price is €30.40. Kobayashi Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €13.71. Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 2.22.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kobayashi Pharmaceutical Co was 7.34. The lowest was 2.02. And the median was 4.63.


Kobayashi Pharmaceutical Co  (FRA:KOY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=30.40/13.71
=2.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kobayashi Pharmaceutical Co was 7.34. The lowest was 2.02. And the median was 4.63.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kobayashi Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Kobayashi Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Kobayashi Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.36 14.59 14.03 14.45 13.59

Kobayashi Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.43 14.08 13.59 13.72 13.71

FRA:KOY vs PG, CL, EL: Cyclically Adjusted Book per Share Comparison

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


FRA:KOY
77GF Score
Kobayashi Pharmaceutical Co Ltd FRA:KOY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobayashi Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kobayashi Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.229/113.6000*113.6000
=15.229

Current CPI (Jun. 2026) = 113.6000.

Kobayashi Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 15.026 98.000 17.418
201612 14.865 98.400 17.161
201703 15.700 98.100 18.181
201706 14.697 98.500 16.950
201709 14.154 98.800 16.274
201712 14.577 99.400 16.659
201803 14.922 99.200 17.088
201806 15.718 99.200 18.000
201809 15.986 99.900 18.178
201812 16.471 99.700 18.767
201903 16.753 99.700 19.089
201906 17.077 99.800 19.438
201909 18.057 100.100 20.492
201912 18.222 100.500 20.597
202003 18.328 100.300 20.758
202006 18.500 99.900 21.037
202009 18.503 99.900 21.040
202012 18.499 99.300 21.163
202103 18.390 99.900 20.912
202106 18.377 99.500 20.981
202109 19.185 100.100 21.772
202112 19.562 100.100 22.200
202203 19.061 101.100 21.418
202206 18.222 101.800 20.334
202209 18.698 103.100 20.602
202212 18.216 104.100 19.878
202303 18.248 104.400 19.856
202306 17.891 105.200 19.320
202309 17.866 106.200 19.111
202312 17.547 106.800 18.664
202403 16.931 107.200 17.942
202406 16.603 108.200 17.432
202409 17.355 108.900 18.104
202412 17.829 110.700 18.296
202503 17.284 111.100 17.673
202506 16.809 111.700 17.095
202509 16.435 112.000 16.670
202512 15.547 113.000 15.630
202603 15.319 112.700 15.441
202606 15.229 113.600 15.229

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €13.71 mean?
Kobayashi Pharmaceutical Co (FRA:KOY) has a Cyclically Adjusted Book per Share of €13.71 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kobayashi Pharmaceutical Co and its competitors.
Is Kobayashi Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Kobayashi Pharmaceutical Co's current Cyclically Adjusted Book per Share is €13.71. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Cyclically Adjusted Book per Share compare to PG and CL?
Kobayashi Pharmaceutical Co's Cyclically Adjusted Book per Share of €13.71 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Book per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Cyclically Adjusted Book per Share is €13.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co (FRA:KOY) is currently considered Modestly Overvalued. The stock's GF Value™ is €26.16, compared to a current price of €30.40 — trading 16.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is €13.71. Kobayashi Pharmaceutical Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (FRA:KOY), the current Cyclically Adjusted Book per Share is €13.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kobayashi Pharmaceutical Co (FRA:KOY) Overvalued in 2026?

Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be overvalued. The current stock price of €30.40 is trading 16.2% above its estimated GF Value™ of €26.16. GuruFocus considers Kobayashi Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for FRA:KOY:

  • Cyclically Adjusted Book per Share: €13.71
  • GF Value™: €26.16 vs. price of €30.40 (16.2% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the FRA:KOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kobayashi Pharmaceutical Co Business Description

Other Exchanges 4967:Japan
Address 4-4-10 Doshomachi, KDX Kobayashi Doshomachi Building, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
77GF Score

Get the complete analysis for FRA:KOY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.40
Price
€26.16
GF Value